Literature DB >> 7889963

Prospective study of renal transplant infections in 50 consecutive patients.

F Martinez-Marcos1, J Cisneros, M Gentil, G Algarra, P Pereira, J Aznar, J Pachon.   

Abstract

A prospective study of the frequency, timing, etiology and risk factors of infections in renal transplant recipients during the first year after transplantation was conducted in 50 consecutive patients. Neither prophylaxis with trimethoprim-sulfamethoxazole nor antiviral prophylaxis was administered. Two hundred twenty-eight episodes of infection were registered (4.5 per patient), 19 of which were severe. Forty-seven percent of all infectious episodes occurred during the first two months after transplantation. The more frequent infections were bacterial (64%), viral (22%) and fungal (11%). Escherichia coli was the most common agent isolated (n = 36), followed by cytomegalovirus (n = 32). Urinary tract infections were most common (n = 144), especially asymptomatic bacteriuria (n = 106). Surgical reintervention and the use of anti-lymphocytic globulins were associated with a higher frequency of severe infections (p < 0.05), and invasive candidiasis was associated with allograft loss (p < 0.03). Annual survival rates of patients and allografts were 100% and 94%, respectively. The frequency of mild infections was higher than that observed in other studies using bacterial or viral prophylaxis. Nevertheless, the number of severe infections and the survival rates of patients and allografts were similar to those reported in previous studies.

Entities:  

Mesh:

Year:  1994        PMID: 7889963     DOI: 10.1007/bf02111821

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Changes in causes of death after renal transplantation, 1966 to 1987.

Authors:  M N Hill; R A Grossman; H I Feldman; S Hurwitz; D C Dafoe
Journal:  Am J Kidney Dis       Date:  1991-05       Impact factor: 8.860

2.  A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.

Authors:  D G Maki; B C Fox; J Kuntz; H W Sollinger; F O Belzer
Journal:  J Lab Clin Med       Date:  1992-01

3.  Fungal infection following renal transplantation.

Authors:  H A Gallis; R A Berman; T R Cate; J D Hamilton; J C Gunnells; D L Stickel
Journal:  Arch Intern Med       Date:  1975-09

4.  Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.

Authors:  J Ruskin; M LaRiviere
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

5.  Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem.

Authors:  P K Peterson; R Ferguson; D S Fryd; H H Balfour; J Rynasiewicz; R L Simmons
Journal:  Medicine (Baltimore)       Date:  1982-11       Impact factor: 1.889

6.  Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.

Authors:  A M Hardy; C P Wajszczuk; A F Suffredini; T R Hakala; M Ho
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

7.  Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation.

Authors:  C S Oh; R J Stratta; B C Fox; H W Sollinger; F O Belzer; D G Maki
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

8.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

9.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

10.  Association between Streptococcus faecalis urinary infections and graft rejection in kidney transplantation.

Authors:  L H Byrd; L Tapia; J S Cheigh; J Aronian; K H Stenzel; A L Rubin
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

View more
  6 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology.

Authors:  D W Denning; E G Evans; C C Kibbler; M D Richardson; M M Roberts; T R Rogers; D W Warnock; R E Warren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

4.  Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study.

Authors:  H Green; R Rahamimov; E Goldberg; L Leibovici; U Gafter; J Bishara; E Mor; M Paul
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-25       Impact factor: 3.267

5.  Urinary tract infections beyond the early post-transplant period in pediatric renal graft recipients.

Authors:  Thomas Mueller; Christoph Resinger; Dagmar Ruffingshofer; Klaus Arbeiter; Egon Balzar; Christoph Aufricht
Journal:  Wien Klin Wochenschr       Date:  2003-06-24       Impact factor: 1.704

6.  A qualitative and quantitative study monitoring airborne fungal flora in the kidney transplant unit.

Authors:  Mohammad Ali Afshari; Majid Riazipour; Reza Kachuei; Mojtaba Teimoori; Behzad Einollahi
Journal:  Nephrourol Mon       Date:  2013-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.